Arbutus Biopharma Corp

XNAS:ABUS

4.56

-0.04 (-0.87%)

7:08:36 PM EDT: $4.64 +0.08 (+1.65%)

Market Cap (Intraday)	892.94M
Current PE	5.56
Forward PE	15.2
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.45 Million
Adjusted EPS	-$0.03

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Arbutus Biopharma Corp Stock, XNAS:ABUS

701 Veterans Circle, Suite 100, Warminster, Pennsylvania 18974

United States of America

Phone: +1.267.469.0914

Number of Employees: 73

http://www.arbutusbio.com

Description

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the Hepatitis B virus, SARS-CoV-2, and other coronaviruses. The company was founded on October 6, 2005 and is headquartered in Warminster, PA.